Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
BW Businessworld

AstraZeneca Partners With Alveofit To Scale Up The Diagnosis, Treatment Of Lung Diseases In India

As a part of the partnership with Alveofit, AstraZeneca has deployed spirometers at selected hospitals across the country. This include ESIC hospitals for industrial employees, Command and Military Hospitals, General Hospitals and last mile clinics in cities like Lucknow, Chennai, Nagpur, Delhi, Ahmedabad and Kolkata

Photo Credit :

AstraZeneca India announced its partnership with Alveofit, a SaaS-IoT enabled respiratory healthcare platform, to offer IoT enabled handheld spirometers at hospitals across the country. 

The partnership aims to embed the latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD. 

As a part of this partnership with Alveofit, AstraZeneca will provide Alveofit IoT enabled handheld spirometers to the clinics and last mile hospitals to enable point of care spirometry for optimized management of different lung associated non-communicable diseases. “This will help track patients remotely and even conduct telespirometry with comprehensive care management solutions,” AstraZeneca India informed in a statement. 

“We believe patient experiences and outcomes are a shared responsibility and innovation doesn’t happen in isolation. Through collaborative innovation, we aspire to address current healthcare challenges, increase affordable and equitable access to healthcare and showcase patient-enabled innovation through partnerships within the health ecosystem. Our ultimate aim is to strengthen and future-proof health systems across the whole patient journey, ensuring everyone has equitable and affordable access to the life-changing healthcare solutions they need, regardless of where they live,” stated Gagandeep Singh, Country President AstraZeneca India. 

As a part of the partnership with Alveofit, AstraZeneca has deployed spirometers at selected hospitals across the country. This include ESIC hospitals for industrial employees, Command and Military Hospitals, General Hospitals and last mile clinics in cities like Lucknow, Chennai, Nagpur, Delhi, Ahmedabad and Kolkata. In a pilot project conducted before starting this initiative, 2800+ patients were tested and around 35-40 per cent were diagnosed with lung issues across all the age groups right from 10-12 year old to 85-90 year old through this deployment. 

“Alveofit-AstraZeneca collaboration is helping the basic respiratory disease diagnostics affordable and accessible at the last mile in public health infrastructure as well as through the corner clinics. These diseases disproportionately affect low-income population given the nature of their living and working conditions. This deployment was the need of the hour given the rising pollution and post COVID-19 world aiding the diagnosis of the respiratory diseases early in the cycle, so as to stop them from progressing ahead and help raise the standard of lives of the patients leading them to live a symptom-free life,” said Dr Prashant Patel, Founder, CEO, Alveofit. 


Tags assigned to this article:
astrazeneca india Alveofit lung diseases